arch 31, 2009 and 46,751,004 shares
issued and 22,370,000 outstanding as of
December 31, 2009) $4,675 $4,146
Additional paid-in capital 82,769,074 7,863,031
Retained earnings 62,557,798 49,794,033
Treasury stock at cost (24,381,004 shares) (2,438) (2,438)
Accumulated other comprehensive income 4,905,867 4,711,788
Capital and statutory reserves 3,025,794 3,025,794
Total stockholders' equity $153,260,770 $65,396,354
Total liabilities and stockholders' equity $222,692,370 $120,804,347
CHINA-BIOTICS, INC. AND SUBSIDIARIES
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(Amounts expressed in US Dollars)
Nine months ended
December 31,
2009 2008
CASH FLOW FROM OPERATING ACTIVITIES
Net income $12,763,702 $$13,377,757
Adjustment for:
Changes in the fair value of embedded
derivatives 6,248,000 (2,073,000)
Loss on disposal of plant and equipment -- 30,022
Change in deferred tax 55,849 500,000
Depreciation 1,423,239 1,298,953
(Increase) in accounts receivable (8,298,996) (792,146)
Decrease in others receivable 267,246 214,989
(Increase) in inventories (630,946) (841,095)
(Increase)/Decrease in prepayments (4,489,544) 1,080
Increase in accounts payable 3,069,677 1,926,337
Increase/(Decrease) in other payables
and accruals
'/>"/>SOURCE China-Biotics, Inc. Copyright©2010 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 Related biology technology :1.
China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.2.
China-Biotics, Inc. Launches Shining Probiotics Protein Powder3.
China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility4.
China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results5.
China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site6.
China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results7.
China-Biotics, Inc. Reports Third Quarter 2008 Financial Results8.
China-Biotics, Inc. Completes Foundation for Its New Plant9.
China-Biotics, Inc. to Present at Two Upcoming Investor Conferences10.
China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company11.
China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results